DRUG.CN
DRUG.CN
CA10919W4056
BrightMindsBio
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
760.52M EUR
1B EUR
994.65M EUR
859.94M EUR
Enterprise Value
417.44M EUR
693.07M EUR
685.04M EUR
770.99M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-9.4x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.47x
3.25x
3.22x
9.63x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.47%
-2.47%
-1.99%
-1.23%
ende